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Abstract Previous studies have suggested that asthma,
like other common diseases, has at least part of its origin
early in life. Low birth weight has been shown to be asso-
ciated with increased risks of asthma, chronic obstructive
airway disease, and impaired lung function in adults, and
increased risks of respiratory symptoms in early childhood.
The developmental plasticity hypothesis suggests that the
associations between low birth weight and diseases in later
life are explained by adaptation mechanisms in fetal life and
infancy in response to various adverse exposures. Various
pathways leading from adverse fetal and infant exposures to
growth adaptations and respiratory health outcomes have
been studied, including fetal and early infant growth pat-
terns, maternal smoking and diet, children’s diet, respira-
tory tract infections and acetaminophen use, and genetic
susceptibility. Still, the specific adverse exposures in fetal
and early postnatal life leading to respiratory disease in
adult life are not yet fully understood. Current studies
suggest that both environmental and genetic factors in
various periods of life, and their epigenetic mechanisms
may underlie the complex associations of low birth weight
with respiratory disease in later life. New well-designed
epidemiological studies are needed to identify the specific
underlying mechanisms. This review is focused on specific
adverse fetal and infant growth patterns and exposures,
genetic susceptibility, possible respiratory adaptations and
perspectives for new studies.
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Asthma in childhood has a high prevalence across many
countries worldwide [1]. The reported prevalence of asthma
is around 5–10% among school-age children and figures are
even higher for asthma related symptoms, such as wheezing,
in younger children. Childhood asthma is related to a reduced
quality of life and exercise tolerance, and higher risks of
school absenteeism and hospitalization [2]. Despite the
availability of effective treatments for symptoms, the mor-
bidity remains high [3]. The lack of curative options seems to
be largely due to the unknown aetiology of asthma [4].
Furthermore, one general definition of asthma is difficult to
define [5]. Objective tests, including spirometry or bronchial
hyperresponsiveness, are not easy to conduct in young
children, and have limited applicability. In epidemiological
studies it is currently well accepted that a diagnosis of asthma
is based on parental- or self-reported symptoms [6]. Because
of these different asthma definitions, it is important to
identify the specific underlying mechanisms for the associ-
ations of exposures in fetal life and infancy with different
asthma related outcomes, which might reflect different
specific structural and functional adaptations.
Several studies, of which some have been published in
the European Journal of Epidemiology have suggested that
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asthma, like other common diseases, has at least part of its
origin early in life [4, 7–41]. Long term follow up studies
in different populations have shown that impaired respi-
ratory health or lung function in early childhood is asso-
ciated with asthma and other respiratory diseases in later
life [42–48]. These studies suggest that lung function and
susceptibility for various respiratory diseases track from
early childhood onwards. Thus, risk factors for wheezing
and asthma or low airway function in childhood might
predispose for respiratory diseases in later life. Examples
of known major risk factors in early childhood for devel-
opment of respiratory disease or low airway function
include exposure to parental smoking or air pollution, no or
shorter period of breastfeeding, obesity, larger family size,
daycare attendance, infectious diseases in early childhood
and acetaminophen use [49–56].
Developmental origins of childhood asthma
Recently, low birth weight has also been shown to be
associated with increased risks of asthma, chronic
obstructive airway disease, and impaired lung function in
adults [57–61]. In term born children, it was found that low
birth weight is associated with increased risks of respira-
tory symptoms in the first 7 years of life [62]. Low birth
weight per se is not likely to be the causal factor leading to
asthma. The same birth weight might be the result of
various growth patterns and different fetal exposures [10,
63]. The developmental plasticity hypothesis suggests that
the associations between low birth weight and diseases in
later life are explained by early adaptation mechanisms in
response to various adverse exposures in fetal life and early
childhood [64]. This hypothesis is supported by extensive
epidemiological evidence showing strong and consistent
associations of low birth weight with the risk of common
diseases in adulthood, including cardiovascular disease,
type 2 diabetes and COPD [10, 64–66]. Developmental
adaptations in fetal life and infancy might also result in
impaired lung growth, leading to smaller airways,
decreased lung volume, and subsequently to an increased
risk of asthma or COPD throughout postnatal life [46, 58,
60, 66, 67]. Reduced diameter of central and small airways
can contribute to the development of childhood asthma
[68–70]. Airway caliber is a key determinant of total
airway resistance and might be related to asthma and
COPD [71]. Other mechanisms underlying the associations
of low birth weight with asthma and respiratory diseases in
childhood and adulthood might include an innate or T
helper 2 skewed immune system, increased allergen
sensitization, inflammation and bronchial hyperreactivity
[72–75]. These different underlying mechanisms may lead
to various phenotypes of asthma with onset at different ages.
Fetal growth characteristics
Studies with information about fetal growth characteristics
in different periods of pregnancy enable identification of
critical fetal periods that might be important for the risk of
asthma and other respiratory diseases [76, 77]. A recent
study suggested no associations of fetal growth character-
istics with the risk of ‘ever wheeze’ until the age of 3 years
[78]. However, when the outcome wheeze was combined
with atopic status of the child, the authors showed that a
SD lower fetal head circumference growth between 11 and
19 weeks was associated with a 10% higher risk of non-
atopic wheeze, and a SD lower fetal abdominal circum-
ference growth between 19 and 34 weeks of gestation was
associated with a 20% higher risk of atopic wheezing.
Another study with retrospectively collected fetal mea-
surements observed that reduced fetal size in first trimester
is associated with increased risks for asthma and airway
obstruction in children aged 10 years [79]. This study did
not take postnatal growth parameters into account. How-
ever, infant weight gain, which is generally higher in
children with a low birth weight, is also associated with
respiratory morbidity in childhood [78, 80]. Recently, a
prospective population-based cohort study among 5,125
children observed that not fetal growth, but weight gain
acceleration in early infancy was associated with increased
risks of asthma symptoms in preschool children, indepen-
dent of fetal growth [81]. These results suggest that early
infancy might be a more critical period for the develop-
ment of asthma. The associations of longitudinally mea-
sured fetal and early childhood growth patterns with
various phenotypes of asthma, lung function and lung
structure in childhood and later life adjusted for potential
confounders remain to be studied in further detail.
In addition to fetal and early childhood growth, preterm
birth is suggested to be associated with asthma and
impaired lung function [81–88]. A recent meta-analysis
showed that preterm birth defined as a gestational age less
than 37 weeks at birth was associated with an 1.07–1.36
increased risk of asthma, depending on the heterogeneity of
the studies, compared with children born at term [82]. This
effect seemed stronger at a younger age but this difference
might reflect differences between study populations rather
than a real age effect. Potential underlying pathways for the
association between preterm birth and asthma are not dis-
entangled yet but might include underdeveloped anatomi-
cal or immunological mechanisms [89, 90], interaction
with environmental factors, such as smoke exposure and
chorioamnionitis [49, 84], or genetic factors [91]. Also, the
degree of immaturity, therapeutic interventions and co-
morbidity might play a role. Recent studies observed
inconsistent results on the associations of gestational age
and risks of asthma for children born late preterm [85, 87,
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88] and children born early preterm with or without
mechanical ventilation [88] or bronchopulmonary dyspla-
sia [86, 92]. Future studies are needed to elaborate on these
aspects.
Maternal smoking and diet
Maternal smoking is the most important adverse fetal
exposure in Western countries, and is strongly associated
with fetal growth retardation and low birth weight [63].
Recent studies have demonstrated that maternal smoking
during pregnancy is associated with increased risks of
wheezing and asthma during childhood [93–99]. Most
studies were not able to assess the effect of maternal
smoking exposure in different periods of pregnancy, which
might be important for identifying critical periods. It is also
not known whether the associations between maternal
smoking during pregnancy and the risk of childhood
asthma are explained by direct intrauterine effects, or
reflect other unmeasured environmental confounders.
Stronger effect estimates for maternal smoking than for
paternal smoking during pregnancy with childhood asthma
would suggest direct intra-uterine effects, whereas similar
effect estimates suggest that the associations are explained
by unmeasured socio-economic, or life style related factors
[100, 101]. Also, as in all observational designs, residual
confounding might still be an issue due to unmeasured
social and life style related factors. This needs to be
explored in detail. Recently, we have demonstrated that
continued maternal smoking throughout pregnancy is
associated with asthma symptoms, including wheezing, in
preschool children [49]. These associations were indepen-
dent of paternal smoking and imply a direct adverse effect
of smoke exposure on fetal lung development. The mech-
anisms by which maternal smoking during pregnancy
affect body and lung growth are not fully understood, but
may include direct toxic effects on the respiratory system
and DNA methylation of genes. Recent studies showed
general and biological pathway specific differences in
DNA methylation patterns in children from mothers who
smoked during pregnancy [102, 103]. Differences in DNA-
methylation within the promoter regions of particular genes
may alter the expression of the gene products related to
growth and lung development. However, it is not known
whether the associations between low birth weight and
respiratory disease can be fully explained by fetal smoke
exposure, and the related changes in DNA methylation.
Suboptimal fetal nutrition, due to maternal obesity or
underweight, insufficient dietary intake, or placental dys-
function might also affect fetal growth and lung develop-
ment [52, 104–107]. Maternal obesity and placenta
dysfunction are strongly related to fetal growth, but their
direct associations with respiratory health in the offspring
are not fully understood yet [10, 108]. Insufficient maternal
dietary intake of macronutrients during pregnancy may
lead to impaired fetal body, lung and airway growth and
subsequently to an increased risk of asthma in childhood
[104, 109–116]. More specifically, maternal Mediterranean
and Western dietary patterns during pregnancy are related
to fetal growth patterns [117, 118]. Thus far, little is known
whether these maternal dietary patterns also affect the risk
of childhood asthma [119]. The mechanisms by which
dietary patterns affect body and lung growth development
may also include DNA methylation [120, 121]. Lower
intake of micronutrients such as folate, and vitamin B12 in
mother’s diet may induce epigenetic changes, since folate
and vitamin B12 are important methyl donors during
pregnancy [122]. Vitamin E has the potential to influence
airway development via epigenetic mechanisms because it
influences gene expression and airway epithelial cell sig-
nalling [112]. The role of epigenetic mechanisms regarding
the association of low maternal vitamin D intake during
pregnancy with a higher incidence of asthma and wheeze in
children is not known yet [123–127]. The importance of the
maternal intake of these micronutrients on respiratory
health in childhood and adulthood might differ between
developing and Western countries, since the nutritional
status of mothers and children in these countries are
different.
Exposures in infancy
After birth, infant diet may also influence body and lung
growth development [128]. Specific infant feeding patterns
such as early introduction of bottle feeding or solid food
instead of a long period of exclusive breastfeeding may
lead to reduced lung and airway growth and increased risk
of childhood asthma [50, 129–132]. Underlying mecha-
nisms that have been suggested to explain the associations
of shorter duration or smaller amount of breastfeeding with
the risks of asthma are breast milk components, including
IgA, cytokines, glycans and long-chain fatty acids that
stimulate and balance the infant’s innate immune system
and growth [133–135]. Atopic and infectious mechanisms
might partly mediate the protective effect of breastfeeding
on childhood asthma [50, 131, 136, 137]. Thus far, previ-
ous studies did report inconsistent results on effect modi-
fication by family history of asthma, allergy and atopy on
the association of breastfeeding with wheezing [131, 136–
139]. Also, the protective effect of a longer period of
breastfeeding duration on childhood asthma still remains
when respiratory tract infections are taken into account
[50]. Further studies are needed to explore in detail the role
of atopy, infections, suboptimal lung growth [128],
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epigenetic changes [140] and other possible underlying
mechanisms in the associations between breastfeeding and
asthma.
In the first years, childhood asthma symptoms or
wheezing are predominantly related to respiratory tract
infections [53, 55, 56, 141, 142]. Respiratory infectious
diseases in infancy also predict the risk of asthma and other
respiratory diseases in childhood and adulthood [66, 143,
144]. Results from the COPSAC study have shown that
colonization of the airways with S. pneumoniae, H. influ-
enzae, M. catarrhalis, or more than one of these organisms
in asymptomatic neonates at 1 month of age was associated
with increased risks of wheezing symptoms, higher blood
eosinophil counts and total IgE, and development of
asthma in school age children [56]. Similarly, nasal car-
riage with S. aureus is associated with an increased risk of
atopic dermatitis [145]. Still, whether these associations
reflect causal mechanisms or reflect symptoms of the same
underlying susceptible lung or skin is not known. Acet-
aminophen is frequently used in children with fever epi-
sodes, including those with upper and lower respiratory
tract infections. Several studies have suggested associa-
tions between acetaminophen in childhood and the risk of
asthma [54, 146–150]. A recent review summarized the
existing evidence for the associations of acetaminophen
use with childhood asthma, and suggested that this asso-
ciation might be causal based on various epidemiological
findings including the strength, consistency, and dose–
response relationship [151]. Also, the metabolism of acet-
aminophen leads to a depletion in airway mucosal gluta-
thione that could contribute to vulnerability to oxidant
stress. Prospective studies relating infectious diseases and
acetaminophen use with different respiratory health out-
comes in adulthood have not been performed yet.
Genetic susceptibility
The associations of low birth weight with respiratory
symptoms in later life might also be explained by common
genetic variants leading to both fetal growth restriction and
smaller lungs and airways and, subsequently, to asthma.
Previous candidate gene studies and linkage studies iden-
tified more than 100 genes associated with asthma [152,
153]. However, most of these associations could not be
replicated. More recent genome wide approaches in large
study populations successfully identified and replicated
genetic variants related to asthma in children [154–160].
Variants in the ORM1-like 3 (ORMDL3) gene and in
neighbouring genes, such as gasdermin A and B (GSDM),
have consistently been associated with risk of childhood
asthma. None of the identified common genetic variants
related to asthma or COPD were associated with birth
weight on a genome wide significant level [161], but this
might be due to lack of power. Thus far, no genome wide
association studies have been performed on lung function
in early childhood. Therefore, further studies are needed
that relate genetic variants to both early body and lung
growth characteristics and respiratory diseases in later life.
The effects of early life exposures such as maternal
smoking and diet, breastfeeding and infant infectious dis-
eases on the risk of asthma and COPD might be modified
by a genetic susceptibility. Recent studies suggest that the
effects of some genetic variants related to asthma, located
on glutathione S-transferase (GST), methylenetetrahydrof-
olate reductase (MTHFR), gasdermin-like (GSDML) and
ORMDL3 genes, are modified by environmental exposures,
including tobacco smoke exposure [116, 162–167]. The
increased risk of early-onset asthma due to 17q21 genetic
variants of ORDML3, GSDML and 2 other genes was
further enhanced by early childhood tobacco smoke
exposure [162, 164]. Also, GST genes in combination with
fetal smoke exposure seem to be associated with lower
airway responsiveness, lung function and increased risk of
transient wheezing, a phenotype of childhood asthma [163,
166]. However, results for effect modification by maternal
smoking on the associations of GST genes with respiratory
morbidity are not consistent [167, 168]. Further gene-
environment studies are needed, especially focused on the
environmental exposures in the fetal period, during which
period alveolar and airway development is largely
completed.
Conclusion
Asthma in childhood is a heterogeneous disease and the
exact underlying origins remain partly unknown. Several
lines of investigation suggest that asthma has at least part
of its origin in fetal life and infancy. Low birth weight
seems to be associated with the risk of childhood asthma,
but may not be the causal factor per se. Therefore, focus for
further research should be beyond birth to identify specific
fetal and infant growth patterns, their specific exposures
and gene-environment interactions leading to asthma and
other respiratory diseases in later life (Fig. 1). Specific
early exposures of interest include maternal smoking and
diet, infant feeding, and infectious diseases in early life.
Developmental adaptation mechanisms in early life that
need to be studied in epidemiological study designs include
DNA methylation, and detailed imaging and functional
assessments of the airways and lungs. Newly identified
contributing factors to the origins of respiratory diseases
including childhood asthma can ultimately contribute to the
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